Share information
Dealing Information
If you would like to deal in Protherics shares these are the relevant details. If you need assistance please click here to read our FAQs.
| Full Name of Company: |
Protherics PLC |
| Market: |
UK list (LSE) |
| Stock Code: |
PTI |
| Sector: |
Pharmaceutical |
| Subsector: |
Biotechnology |
| Indices: |
FTSE ALL-SHARE; FTSE techMARK 100; FTSE techMARK All-Share; FTSE techMARK mediscience; FTSE SMALLCAP |
| Trading System: |
SEAQ |
| Settlement: |
Crest |
Protherics has established an American Depositary Receipt
| Market: |
NASDAQ National Market |
| Ticker: |
PTIL |
| ADR ratio: |
One (1) Protherics ADR represents ten (10) ordinary shares of the Company |
| ADR CUSIP: |
743707101 |
| Depositary bank: |
The Bank of New York |
Number of shares in issue
As at 10 December 2007: 339,950,033
Major shareholders
Shareholders with 3% or more interest in the Company as at 10th February 2008.
| AXA Framlington Investment Managers |
12.33% |
| Morley Fund Management |
11.96% |
| Invesco Perpetual |
11.84% |
| Insight Investment |
5.93% |
| Individuals holding 100k or more shares 4.48% |
4.48% |
| Legal & General Investment Management |
4.39% |
| M & G Investment Management |
3.50% |
| Fidelity Investments |
3.34% |
| AstraZeneca |
3.23% |
Artemis Investment Management
|
3.12%
|
Further details of shareholder analysis can be found in the latest annual report.